Cyberattacks to cost $305B over next five years

Cyberattacks over the next five years will cost U.S. health systems $305 billion in cumulative lifetime revenue, according to a report from Accenture.

One in 13 patients, about 25 million people, will have personal information stolen from technology systems over the next five years, according to the consulting firm.

“What most health systems don’t realize is that many patients will suffer personal financial loss as a result of cyberattacks on medical information,” said Kaveh Safavi, MD, JD, managing director of Accenture's global healthcare business. “If healthcare providers are complacent to safeguarding personal information, they’ll risk losing substantial revenues and patients as a result of medical identity theft.”
 
Nearly 1.6 million people had their medical information stolen from healthcare providers in 2014, according to the U.S. Department of Health and Human Services Office for Civil Rights. Unlike credit card identity theft, where the card provider generally has a legal responsibility for account holders’ losses above $50, victims of medical identity theft often have no automatic right to recover their losses.
 
Accenture projects that of the patients likely to be affected by healthcare-provider data breaches over the next five years, one-quarter will subsequently become victims of medical identity theft. One in six (16 percent) of the affected patients will be victimized and pay out-of-pocket costs totaling almost $56 billion over the same time period.
 
Addressing cybersecurity proactively can improve a provider’s ability to thwart attacks by an average of 53 percent, Accenture research shows. Yet, according to the Accenture report, there is a significant gap in how well prepared they are to deal with such inevitabilities.
 
“In the end, when a breach occurs, the goal is not to say ‘what is our plan,’ but, ‘how is our plan working?’” Safavi said. 
Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.